Let-7a-5p inhibits BMSCs osteogenesis in postmenopausal osteoporosis mice
Wenpu Ma1, Qingjun Dou1, Xin Ha2
1Department of Orthopaedics, Liaocheng People's Hospital, No. 67 Dongchang West Road, Liaocheng City, Shandong Province, 252000, China.
Purpose:
The aim of this study was to investigate the mechanism of let-7a-5p in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in postmenopausal osteoporosis (PMOP) mice.
Methods:
A mouse model of PMOP was established and osteoporosis model was identified by micro-CT scan. BMSCs in the sham group and PMOP group were cultured and osteogenic differentiation was induced. The expression of let-7a-5p in BMSCs was detected by qRT-PCR, and BMSCs was induced by osteogenic differentiation in sham and PMOP group. The BMSCs treated by let-7a-5p mimics, let-7a-5p inhibitor and negative control were named as let-7a-5p mimics group, mimics NC group, let-7a-5p inhibitor group and inhibitor NC group, respectively. ALP staining and alizarin red staining were used to detect osteogenic differentiation ability, qRT-PCR and western blot were used to detect the expression of Runt-related transcription factor 2 (Runx2) and Osterix. The targeting relationship between let-7a-5p and TGFBR1 were verificated by target scan and luciferase reporter gene assay.
Results:
The PMOP mouse model was successfully established. The expression of let-7a-5p in BMSCs of PMOP group was significantly higher than that in the sham group (P < 0.05). Let-7a-5p reduced the expression of ALP and the formation of calcified nodules, while also inhibited the expression of Runx2 and Osterix. TGFBR1 is the target gene of let-7a-5p.
Conclusion:
Let-7a-5p might inhibit the osteogenic differentiation of BMSCs in PMOP mice by regulating TGFBR1.
Insights
High let-7a-5p levels inhibit bone marrow mesenchymal stem cell differentiation in osteoporosis. This microRNA targets TGFBR1, suggesting a mechanism for postmenopausal osteoporosis.
Area of Science:
- Biomedical research
- Stem cell biology
- Osteoporosis research
Background:
- Postmenopausal osteoporosis (PMOP) is a significant health concern.
- Bone marrow mesenchymal stem cells (BMSCs) play a crucial role in bone formation.
- Understanding the molecular mechanisms regulating BMSC osteogenic differentiation is vital for PMOP treatment.
Purpose of the Study:
- To investigate the role of microRNA let-7a-5p in the osteogenic differentiation of BMSCs.
- To elucidate the mechanism by which let-7a-5p affects BMSC function in a mouse model of PMOP.
- To identify potential molecular targets of let-7a-5p involved in osteoporosis.
Main Methods:
- Established a mouse model of PMOP and confirmed using micro-CT.
- Cultured BMSCs from sham and PMOP mice, inducing osteogenic differentiation.
- Quantified let-7a-5p expression via qRT-PCR and assessed osteogenic markers (ALP, alizarin red, Runx2, Osterix) using qRT-PCR and Western blot.
- Validated the targeting relationship between let-7a-5p and TGFBR1 using luciferase reporter gene assays.
Main Results:
- The PMOP mouse model was successfully established.
- let-7a-5p expression was significantly upregulated in BMSCs from PMOP mice compared to sham controls.
- Overexpression of let-7a-5p inhibited BMSC osteogenic differentiation, evidenced by reduced ALP activity and calcified nodule formation.
- let-7a-5p suppressed the expression of key osteogenic transcription factors, Runx2 and Osterix.
- TGFBR1 was confirmed as a direct target gene of let-7a-5p.
Conclusions:
- let-7a-5p acts as an inhibitor of osteogenic differentiation in BMSCs.
- The inhibitory effect of let-7a-5p on osteogenesis in PMOP mice is mediated through the regulation of its target gene, TGFBR1.
- Targeting the let-7a-5p/TGFBR1 axis may offer a therapeutic strategy for postmenopausal osteoporosis.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Inhibition of Cdk Activity
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
MicroRNAs


